Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$38.3M Sell
1,363,429
-476,185
-26% -$13.4M 0.37% 53
2014
Q2
$51.8M Buy
1,839,614
+344,023
+23% +$9.81M 0.5% 31
2014
Q1
$45.6M Buy
1,495,591
+13,361
+0.9% +$398K 0.45% 35
2013
Q4
$43.1M Sell
1,482,230
-48,766
-3% -$1.42M 0.41% 49
2013
Q3
$41.7M Sell
1,530,996
-45,556
-3% -$1.24M 0.46% 37
2013
Q2
$41.9M Buy
+1,576,552
New +$43.6M 0.51% 37

Other funds holding PFE

SEI Trust Company's PFE Position: Q3 2014 in Review

SEI Trust Company reduced its Pfizer (PFE) stake by 26% in Q3 2014, selling an estimated $13.4M and leaving 1,363,429 shares worth $38.3M. The position accounts for 0.37% of the portfolio, ranked #53.

SEI Trust Company first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. The position peaked at $51.8M in Q2 2014. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • SEI Trust Company held 1,363,429 shares of Pfizer worth $38.3M as of Q3 2014.
  • SEI Trust Company sold 476,185 Pfizer shares in Q3 2014, an estimated $13.4M.
  • Pfizer made up 0.37% of SEI Trust Company's portfolio in Q3 2014, its #53 holding.
  • SEI Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • SEI Trust Company's Pfizer position peaked at $51.8M in Q2 2014.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.